Mesenchymal Stem Cells: A Potential Therapeutic Strategy for Neurodegenerative Diseases | Zendy

Panpan Yao | Zendy; Liping Zhou | Zendy; Lujie Zhu | Zendy; Binjie Zhou | Zendy; Qin Yu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Mesenchymal Stem Cells: A Potential Therapeutic Strategy for Neurodegenerative Diseases

Author(s) -

Panpan Yao,

Liping Zhou,

Lujie Zhu,

Binjie Zhou,

Qin Yu

Publication year - 2020

Publication title -

european neurology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.573

H-Index - 77

eISSN - 1421-9913

pISSN - 0014-3022

DOI - 10.1159/000509268

Subject(s) - mesenchymal stem cell , induced pluripotent stem cell , regenerative medicine , stem cell , disease , stem cell therapy , cell therapy , medicine , neuroscience , biology , cancer research , pathology , embryonic stem cell , microbiology and biotechnology , biochemistry , gene

Neurodegenerative disease is a kind of chronic, progressive nervous system disease characterized by neuron degeneration or apoptosis. Current treatments cannot prevent the development of the disease. Possible alternative treatments include cell therapy, especially with the use of mesenchymal stem cells (MSCs). MSCs are pluripotent stem cells with capacities for self-renewal and multidirectional differentiation. MSCs may serve as a reliable source of neural cells for potential cell replacement therapy or regenerative medicine treatment. Here, we summarized the therapeutic mechanisms of MSCs and how they can contribute to the development of treatments for neurodegenerative diseases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research